Mellaras

Melatonin, the active ingredient in Mellaras, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate the sleep‑wake cycle and to promote sleep onset in adults experiencing insomnia, jet lag, or other circadian rhythm disturbances.

GNH USA supplies Mellaras as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable sourcing for regulated markets. Products are shipped through established distribution networks ensuring timely delivery.

Mellaras (melatonin) acts on the melatonin receptor pathway to address sleep‑related disorders. - Insomnia: reduces the time needed to fall asleep and may improve overall sleep continuity and subjective sleep quality in adults with difficulty initiating sleep. - Jet lag: facilitates adjustment of the internal clock to new time zones, helping travelers achieve a more rapid alignment of sleep timing after east‑west or west‑east flights. - Sleep‑wake rhythm disorders: aids in stabilizing abnormal circadian patterns such as shift‑work disorder or delayed sleep phase, promoting a more regular sleep‑wake schedule.

Mellaras may be associated with a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Drowsiness: feeling of increased sleepiness during daytime. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness. - Gastrointestinal discomfort: nausea or abdominal cramps. - Fatigue: persistent tiredness despite rest. - Night sweats: occasional sweating during sleep. Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: vivid dreams, irritability, or depressive symptoms. - Hormonal effects: alterations in reproductive hormone levels, though rare.

When considering Mellaras, several precautionary measures should be observed to ensure safe use. - Assess patient history: evaluate for underlying sleep disorders, depression, or seizure disorders. - Avoid use with driving: caution patients about possible daytime drowsiness. - Pregnancy and lactation: discuss potential risks with healthcare provider. - Concomitant medications: review for possible interactions, especially with CNS depressants. - Age considerations: use lower doses in elderly patients due to increased sensitivity. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Melatonin can interact with several medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce drug levels. - Sedatives (benzodiazepines, barbiturates): additive CNS depression. Moderate Interactions (Monitor Closely): - Oral contraceptives: melatonin may diminish contraceptive effectiveness. - Antidepressants (SSRIs, MAOIs): potential for altered serotonin levels. - Antihypertensives: possible additive blood pressure lowering effect.